Katherine Vilain

995 total citations
17 papers, 701 citations indexed

About

Katherine Vilain is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katherine Vilain has authored 17 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katherine Vilain's work include Coronary Interventions and Diagnostics (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Katherine Vilain is often cited by papers focused on Coronary Interventions and Diagnostics (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Katherine Vilain collaborates with scholars based in United States, Canada and Philippines. Katherine Vilain's co-authors include Elizabeth A. Magnuson, David J. Cohen, Kaijun Wang, Matthew R. Reynolds, Yang Lei, Craig R. Smith, Martin B. Leon, Susheel Kodali, William W. O’Neill and John M. Lasala and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Stroke.

In The Last Decade

Katherine Vilain

16 papers receiving 676 citations

Peers

Countries citing papers authored by Katherine Vilain

Since Specialization

Citations

This map shows the geographic impact of Katherine Vilain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Vilain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Vilain more than expected).

Fields of papers citing papers by Katherine Vilain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Vilain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Vilain. The network helps show where Katherine Vilain may publish in the future.

Co-authorship network of co-authors of Katherine Vilain

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Vilain. A scholar is included among the top collaborators of Katherine Vilain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Vilain. Katherine Vilain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Decision analysis model of rapid versus deferred antibiotic initiation in patients with suspected sepsis in the emergency department 2025 ·Intensive Care Medicine ·(unknown), (unknown), Katherine Vilain, Sam Windham, (unknown), Steven Q. Simpson, Christopher A. Guidry	0
2	Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial 2022 ·Circulation Cardiovascular Interventions ·Elizabeth A. Magnuson, Khaja Chinnakondepalli, Katherine Vilain, Patrick W. Serruys, Joseph F. Sabik, A. Pieter Kappetein, Gregg W. Stone, David J. Cohen, (unknown)	8
3	Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial 2021 ·Journal of Medical Economics ·Elizabeth A. Magnuson, Haiyan Li, Katherine Vilain, Ehrin J. Armstrong, Eric A. Secemsky, Stefanos Giannopoulos, George L. Adams, Jihad Mustapha, David J. Cohen, (unknown)	7
4	Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial 2020 ·Circulation Cardiovascular Quality and Outcomes ·Katherine Vilain, Haiyan Li, (unknown), Elliott M. Antman, Christian T. Ruff, Eugene Braunwald, David J. Cohen, Robert P. Giugliano, Elizabeth A. Magnuson, (unknown)	7
5	Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis 2019 ·Circulation Cardiovascular Quality and Outcomes ·Elizabeth A. Magnuson, Khaja Chinnakondepalli, Katherine Vilain, Clive Kearon, Jim A. Julian, Susan R. Kahn, Samuel Z. Goldhaber, Michael R. Jaff, Andrei Kindzelski, (unknown), Paul S. Brady, Karun Sharma, Carl M. Black, Suresh Vedantham, David J. Cohen	21
6	Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention 2017 ·JACC: Cardiovascular Interventions ·Suzanne J. Baron, Yang Lei, Khaja Chinnakondepalli, Katherine Vilain, Elizabeth A. Magnuson, Dean J. Kereiakes, Stephen G. Ellis, Gregg W. Stone, David J. Cohen	6
7	Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction 2017 ·Journal of the American College of Cardiology ·Elizabeth A. Magnuson, Haiyan Li, Kaijun Wang, Katherine Vilain, Ali Shafiq, Marc P. Bonaca, Deepak L. Bhatt, Marc Cohen, Philippe Gabríel Steg, Robert F. Storey, Eugene Braunwald, Marc S. Sabatine, David J. Cohen	18
8	Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome 2017 ·Circulation Cardiovascular Quality and Outcomes ·Yashashwi Pokharel, Khaja Chinnakondepalli, Katherine Vilain, Kaijun Wang, Daniel B. Mark, Glenn Davies, Michael A. Blazing, Robert P. Giugliano, Eugene Braunwald, Christopher P. Cannon, (unknown), Elizabeth A. Magnuson	7
9	Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty 2016 ·JACC: Cardiovascular Interventions ·Adam C. Salisbury, Haiyan Li, Katherine Vilain, Michael R. Jaff, Peter A. Schneider, John R. Laird, David J. Cohen	38
10	Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF–TIMI 48 trial 2015 ·American Heart Journal ·Elizabeth A. Magnuson, Katherine Vilain, Kaijun Wang, Haiyan Li, Winghan Jacqueline Kwong, Elliott M. Antman, Christian T. Ruff, Robert P. Giugliano, David J. Cohen	23
11	Abstract 16534: Cost-Effectiveness of Edoxaban vs. Warfarin in Patients With Atrial Fibrillation: Results From the ENGAGE AF - TIMI 48 Economic Study 2014 ·Elizabeth A. Magnuson, Katherine Vilain, Kaijun Wang, Haiyan Li, Winghan Jacqueline Kwong, Elliott M. Antman, Christian T. Ruff, (unknown), David J. Cohen	1
12	Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease 2013 ·Circulation ·Elizabeth A. Magnuson, Michael E. Farkouh, Valentı́n Fuster, Kaijun Wang, Katherine Vilain, Haiyan Li, (unknown), Victoria Muratov, Lynn A. Sleeper, Robin Boineau, Mouin Abdallah, David J. Cohen	86
13	Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis 2012 ·Journal of the American College of Cardiology ·Matthew R. Reynolds, Elizabeth A. Magnuson, Yang Lei, Kaijun Wang, Katherine Vilain, Haiyan Li, (unknown), Duane S. Pinto, Vinod H. Thourani, Lars G. Svensson, Michael J. Mack, D. Craig Miller, Lowell Satler, Joseph E. Bavaria, Craig R. Smith, Martin B. Leon, David J. Cohen	178
14	Use of Drug-Eluting Stents as a Function of Predicted Benefit 2012 ·Archives of Internal Medicine ·Amit P. Amin, John A. Spertus, David J. Cohen, Adnan K. Chhatriwalla, Kevin F. Kennedy, Katherine Vilain, Adam C. Salisbury, Lakshmi Venkitachalam, Sue Min Lai, Laura Mauri, Sharon‐Lise T. Normand, John S. Rumsfeld, John C. Messenger, Robert W. Yeh	47
15	Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis 2012 ·Circulation ·Matthew R. Reynolds, Elizabeth A. Magnuson, Kaijun Wang, Yang Lei, Katherine Vilain, (unknown), Susheel Kodali, John M. Lasala, William W. O’Neill, Charles J. Davidson, Craig R. Smith, Martin B. Leon, David J. Cohen	202
16	Cost–Effectiveness of Everolimus- Versus Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization (from the SPIRIT-IV Trial) 2012 ·The American Journal of Cardiology ·Amit P. Amin, Matthew R. Reynolds, Yang Lei, Elizabeth A. Magnuson, Katherine Vilain, Amy J. Durtschi, Charles A. Simonton, Gregg W. Stone, David J. Cohen	7
17	Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at Standard Surgical Risk 2012 ·Stroke ·Katherine Vilain, Elizabeth A. Magnuson, Haiyan Li, Wayne M. Clark, Richard J. Begg, Albert D. Sam, W. Charles Sternbergh, Fred A. Weaver, William A. Gray, Jenifer H. Voeks, Thomas G. Brott, David J. Cohen	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact